These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12839923)

  • 1. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
    Vijayachandra K; Lee J; Glick AB
    Cancer Res; 2003 Jul; 63(13):3447-52. PubMed ID: 12839923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.
    Tannehill-Gregg SH; Kusewitt DF; Rosol TJ; Weinstein M
    Vet Pathol; 2004 May; 41(3):278-82. PubMed ID: 15133179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
    Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
    Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH; He W; Olson KL; Wang XJ
    Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M; Verrecchia F; Mauviel A
    Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis.
    Li AG; Lu SL; Zhang MX; Deng C; Wang XJ
    Cancer Res; 2004 Nov; 64(21):7836-45. PubMed ID: 15520189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer.
    Han SU; Kim HT; Seong DH; Kim YS; Park YS; Bang YJ; Yang HK; Kim SJ
    Oncogene; 2004 Feb; 23(7):1333-41. PubMed ID: 14647420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
    Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion.
    Cui W; Kemp CJ; Duffie E; Balmain A; Akhurst RJ
    Cancer Res; 1994 Nov; 54(22):5831-6. PubMed ID: 7954410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
    Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
    Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
    Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.